Our results suggest that combination therapy with cyclosporine and eltrombopag exhibits better response rates in settings of the existence of contraindications to other therapies and less efficacy of eltrombopag alone. This knowledge will be helpful for other clinicians to choose an appropriate treatment in such difficult circumstances.
Zheng et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: